Hirudoid

Hirudoid is a topical cream containing 0.5% w/w glycosaminoglycan polysulfate, a heparinoid approved in the EU for prescription use. The formulation is applied to the skin to address localized bruising, edema, and related inflammatory conditions. As a heparinoid, it works locally to improve microcirculation and reduce swelling without systemic anticoagulant effects. It is intended for external use on intact skin; it should be stored at temperature away from direct sunlight.

Hirudoid cream is prescribed for several superficial vascular and inflammatory skin conditions where localized swelling or bruising is present.

- Bruising (contusions) that develop after minor trauma, especially on the limbs. - Superficial thrombophlebitis affecting small cutaneous veins, presenting with redness and tenderness. - Hematoma formation following blunt injury, where localized blood collection causes swelling. - Localized edema linked to venous insufficiency or prolonged standing, leading to fluid buildup. - Discomfort or mild inflammation associated with varicose veins, especially after prolonged activity. - Post‑procedural swelling after minor dermatologic interventions.

Topical application of Hirudoid may cause skin reactions, most of which are mild and reversible.

Common: - Mild itching or burning at the application site. - Redness or mild erythema. - Slight stinging sensation. - Dryness or peeling of the treated skin.

Serious: - Allergic contact dermatitis with extensive rash. - Severe swelling or urticaria. - Bullous formation or skin necrosis (rare).

When using Hirudoid, certain precautions help minimize adverse reactions and ensure safe use.

- Apply only to intact or mildly irritated skin; avoid open wounds. - Do not use on infected, ulcerated or severely damaged areas. - Limit application to the prescribed area and avoid excessive amounts. - Discontinue use if signs of allergic reaction develop. - Keep out of reach of children; accidental ingestion may cause systemic effects. - Avoid concurrent use with other topical heparinoids unless directed by a physician. - Pregnant or nursing women should consult a healthcare professional before use.

Hirudoid can interact with other topical agents or systemic medications that affect coagulation or skin integrity.

Avoid: - Concurrent use with other topical heparinoids or anticoagulant creams. - Application over areas treated with strong irritants or chemical peels.

Use with caution: - Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants) – monitor for increased bleeding if large skin areas are treated. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically – assess for additive irritation. - Corticosteroid creams – consider potential alteration of skin barrier.